A current view of G protein-coupled receptor - mediated signaling in pulmonary hypertension: finding opportunities for therapeutic intervention

Abstract

Pathological vascular remodeling is observed in various cardiovascular diseases including pulmonary hypertension (PH), a disease of unknown etiology that has been characterized by pulmonary artery vasoconstriction, right ventricular hypertrophy, vascular inflammation, and abnormal angiogenesis in pulmonary circulation. G protein-coupled receptors (GPCRs) are the largest family in the genome and widely expressed in cardiovascular system. They regulate all aspects of PH pathophysiology and represent therapeutic targets. We overview GPCRs function in vasoconstriction, vasodilation, vascular inflammation-driven remodeling and describe signaling cross talk between GPCR, inflammatory cytokines, and growth factors. Overall, the goal of this review is to emphasize the importance of GPCRs as critical signal transducers and targets for drug development in PH.

Keywords

Pulmonary hypertension / vascular remodeling / vasoconstriction / vascular inflammation / GPCR / intracellular signaling

References

[1] Strange G,Stewart S,Nelson H,Gabbay E.Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort.Heart2012;98:1805-11 PMCID:PMC3533383

[2] Joppi R,Bertele V.A disease looking for innovative drugs: the case of pulmonary arterial hypertension.Eur J Intern Med2018;55:47-51

[3] Thomsen W,Unett D.Functional assays for screening GPCR targets.Curr Opin Biotechnol2005;16:655-65

[4] Salazar NC,Rockman HA.Cardiac GPCRs: GPCR signaling in healthy and failing hearts.Biochim Biophys Acta2007;1768:1006-18 PMCID:PMC1892229

[5] Offermanns S.Organization of transmembrane signalling by heterotrimeric G proteins..Cancer Surv1996;27:177-98

[6] Rajagopal S.GPCR desensitization: acute and prolonged phases.Cell Signal2018;41:9-16

[7] Kach J,Dulin NO.A finer tuning of G-protein signaling through regulated control of RGS proteins.Am J Physiol Heart Circ Physiol2012;303:H19-35 PMCID:PMC3404647

[8] Tan JL,Spudich JA.Control of nonmuscle myosins by phosphorylation.Annu Rev Biochem1992;61:721-59

[9] Ikebe M.Phosphorylation of smooth muscle myosin at two distinct sites by myosin light chain kinase.J Biol Chem1985;260:10027-31

[10] Amano M,Kimura K,Chihara K,Matsuura Y.Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase).J Biol Chem1996;271:20246-9

[11] Yamamura A.Pathological function of Ca2+-sensing receptor in pulmonary arterial hypertension.J Smooth Muscle Res2014;50:8-17 PMCID:PMC5137257

[12] Smith KA,Tang H,Yuan JX.Calcium-sensing receptor regulates cytosolic [Ca (2+) ] and plays a major role in the development of pulmonary hypertension.Front Physiol2016;7:517 PMCID:PMC5095111

[13] Ota H,Ito M,Oka M.S1P(4) receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs.Pulm Circ2011;1:399-404 PMCID:PMC3224432

[14] Aiello RJ,Zhang Q,Goldberg DR,Humbert M,Cavasin MA,Paralkar V.Tryptophan hydroxylase 1 inhibition impacts pulmonary vascular remodeling in two rat models of pulmonary hypertension.J Pharmacol Exp Ther2017;360:267-79

[15] Bhat L,Cantillon M,Bhat SR,Bouchard A,Salvail D.RP5063, a novel, multimodal, serotonin receptor modulator, prevents Sugen 5416-hypoxia-induced pulmonary arterial hypertension in rats.Eur J Pharmacol2017;810:83-91

[16] Liu Y,Warburton R,Fanburg BL.Serotonin induces Rho/ROCK-dependent activation of Smads 1/5/8 in pulmonary artery smooth muscle cells.FASEB J2009;23:2299-306

[17] Mori MX,Hase H,Kurokawa T,Inoue R.Dynamics of receptor-operated Ca(2+) currents through TRPC channels controlled via the PI(4,5)P2-PLC signaling pathway.Front Pharmacol2015;6:22 PMCID:PMC4324076

[18] Kong F,Zou L,Ji T,Zhang R.Alpha1-adrenergic receptor activation stimulates calcium entry and proliferation via TRPC6 channels in cultured human mesangial cells.Cell Physiol Biochem2015;36:1928-38

[19] Tanabe S,Suzuki N.Regulation of RGS-RhoGEFs by Galpha12 and Galpha13 proteins.Methods Enzymol2004;390:285-94

[20] Mahavadi S,Al-Shboul O.Inhibition of MLC20 phosphorylation downstream of Ca2+ and RhoA: a novel mechanism involving phosphorylation of myosin phosphatase interacting protein (M-RIP) by PKG and stimulation of MLC phosphatase activity.Cell Biochem Biophys2014;68:1-8 PMCID:PMC3836910

[21] Horinouchi T,Aoyagi H,Terada K.Adenylate cyclase/cAMP/protein kinase A signaling pathway inhibits endothelin type A receptor-operated Ca(2)(+) entry mediated via transient receptor potential canonical 6 channels.J Pharmacol Exp Ther2012;340:143-51

[22] Nalli AD,Al-Shboul O,Kuemmerle JF,Murthy KS.Regulation of Gbetagammai-dependent PLC-beta3 activity in smooth muscle: inhibitory phosphorylation of PLC-beta3 by PKA and PKG and stimulatory phosphorylation of Galphai-GTPase-activating protein RGS2 by PKG.Cell Biochem Biophys2014;70:867-80 PMCID:PMC4184950

[23] Huang J,Mahavadi S,Murthy KS.Inhibition of Galphaq-dependent PLC-beta1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2.Am J Physiol Cell Physiol2007;292:C200-8

[24] Zieba BJ,Jin L,Ho R,Neppl RL,Khromov AS,Somlyo AV.The cAMP-responsive Rap1 guanine nucleotide exchange factor, Epac, induces smooth muscle relaxation by down-regulation of RhoA activity.J Biol Chem2011;286:16681-92 PMCID:PMC3089510

[25] Moon MY,Kim JG,Kim J,Choi IG,Park JB.Small GTPase Rap1 regulates cell migration through regulation of small GTPase RhoA activity in response to transforming growth factor-beta1.J Cell Physiol2013;228:2119-26

[26] Dimmeler S,Fisslthaler B,Busse R.Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation.Nature1999;399:601-5

[27] Nishida M,Sato Y,Kitajima N,Inoue R.Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.J Biol Chem2010;285:13244-53 PMCID:PMC2857061

[28] Murthy KS,Grider JR.Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of RhoA.Am J Physiol Gastrointest Liver Physiol2003;284:G1006-16

[29] Rolli-Derkinderen M,Boyer L,Baron C,Loirand G.Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells.Circ Res2005;96:1152-60

[30] Luykenaar KD.Activators of the PKA and PKG pathways attenuate RhoA-mediated suppression of the KDR current in cerebral arteries.Am J Physiol Heart Circ Physiol2007;292:H2654-63

[31] Omori K.Overview of PDEs and their regulation.Circ Res2007;100:309-27

[32] Murthy KS.Contractile agonists attenuate cGMP levels by stimulating phosphorylation of cGMP-specific PDE5; an effect mediated by RhoA/PKC-dependent inhibition of protein phosphatase 1.Br J Pharmacol2008;153:1214-24 PMCID:PMC2275441

[33] Luo L,Lian G,Li L,Xie L.Combination treatment of adipose-derived stem cells and adiponectin attenuates pulmonary arterial hypertension in rats by inhibiting pulmonary arterial smooth muscle cell proliferation and regulating the AMPK/BMP/Smad pathway.Int J Mol Med2018;41:51-60

[34] Li HH,Chang GJ,Ho WJ,Chen WJ,Huang CC.Prostanoid EP4 agonist L-902,688 activates PPARgamma and attenuates pulmonary arterial hypertension.Am J Physiol Lung Cell Mol Physiol2018;314:L349-L59

[35] Nakagawa Y,Kihara S,Shimomura I.Adiponectin ameliorates hypoxia-induced pulmonary arterial remodeling.Biochem Biophys Res Commun2009;382:183-8

[36] Isobe S,Kawakami T.Adiponectin in chronic thromboembolic pulmonary hypertension.Circ J2018;82:1466-8

[37] Telli G,Yersal N,Gumusel B.Effect of intermedin/adrenomedullin2 on the pulmonary vascular bed in hypoxia-induced pulmonary hypertensive rats.Life Sci2018;192:62-7

[38] Chawla S,Saxena S.S1P prophylaxis mitigates acute hypobaric hypoxia-induced molecular, biochemical, and metabolic disturbances: a preclinical report.IUBMB Life2016;68:365-75

[39] Harada-Shiba M,Miyata K,Nishiyama N,Kangawa K,Asada Y,Nagaya N.Intratracheal gene transfer of adrenomedullin using polyplex nanomicelles attenuates monocrotaline-induced pulmonary hypertension in rats.Mol Ther2009;17:1180-6 PMCID:PMC2835223

[40] Burnouf C.Recent advances in PDE4 inhibitors as immunoregulators and anti-inflammatory drugs.Curr Pharm Des2002;8:1255-96

[41] Tobin JV,Shea C,Bernier SG,Long K,Ranganath S,Tang K,Sheppeck J2nd,Sykes K,Sarno R,Profy AT,Currie MG.Pharmacological characterization of IW-1973, a novel soluble guanylate cyclase stimulator with extensive tissue distribution, antihypertensive, anti-inflammatory, and antifibrotic effects in preclinical models of disease.J Pharmacol Exp Ther2018;365:664-75

[42] Stelzner TJ,Yanagisawa M,Sato K,Zamora M,Fisher JH.Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension.Am J Physiol1992;262:L614-20

[43] Humbert M,Sitbon O,Callebert J,Samuel D,Trembath R,Launay JM.Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis.Eur Respir J2002;20:59-65

[44] Hood KY,Harvey AP,Touyz RM.Serotonin signaling through the 5-HT1B receptor and NADPH oxidase 1 in pulmonary arterial hypertension.Arterioscler Thromb Vasc Biol2017;37:1361-70 PMCID:PMC5478178

[45] Christman BW,Newman JH,Bernard GR,Loyd JE.An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.N Engl J Med1992;327:70-5

[46] Mahajan CN,Eis A,Konduri GG.Altered prostanoid metabolism contributes to impaired angiogenesis in persistent pulmonary hypertension in a fetal lamb model.Pediatr Res2015;77:455-62 PMCID:PMC4346417

[47] Li H,Chen YF.Increased endothelin receptor gene expression in hypoxic rat lung.Am J Physiol1994;266:L553-60

[48] Weir EK,Varghese A.The serotonin transporter: a vehicle to elucidate pulmonary hypertension?.Circ Res2004;94:1152-4

[49] Wort SJ,Warner TD,Mitchell JA.Cyclooxygenase-2 acts as an endogenous brake on endothelin-1 release by human pulmonary artery smooth muscle cells: implications for pulmonary hypertension.Mol Pharmacol2002;62:1147-53

[50] Chandra SM,Kim J,Kundu RK,Zamanian RT,Chun HJ.Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension.Arterioscler Thromb Vasc Biol2011;31:814-20 PMCID:PMC3113525

[51] Yang P,Davenport AP.Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system.Trends Pharmacol Sci2015;36:560-7 PMCID:PMC4577653

[52] Yang P,Kuc RE,Southwood M,Upton PD,Sawiak SJ,Glen RC,Maguire JJ.Elabela/Toddler is an endogenous agonist of the apelin apj receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension.Circulation2017;135:1160-73 PMCID:PMC5363837

[53] Fediuk J,Nolette N.Thromboxane-induced actin polymerization in hypoxic pulmonary artery is independent of Rho.Am J Physiol Lung Cell Mol Physiol2012;302:L13-26

[54] Hinton M,Dakshinamurti S.Thromboxane hypersensitivity in hypoxic pulmonary artery myocytes: altered TP receptor localization and kinetics.Am J Physiol Lung Cell Mol Physiol2007;292:L654-63

[55] Sikarwar AS,Santhosh KT,Dakshinamurti S.Palmitoylation of Galphaq determines its association with the thromboxane receptor in hypoxic pulmonary hypertension.Am J Respir Cell Mol Biol2014;50:135-43

[56] Santhosh KT,Nolette N,Halayko AJ.Milrinone attenuates thromboxane receptor-mediated hyperresponsiveness in hypoxic pulmonary arterial myocytes.Br J Pharmacol2011;163:1223-36 PMCID:PMC3144536

[57] Rondelet B,Kerbaul F,Fesler P,Brimioulle S,Naeije R.Expression of the serotonin 1b receptor in experimental pulmonary hypertension.Eur Respir J2003;22:408-12

[58] Milara J,Juan G,Guijarro R,Morcillo EJ.Bosentan inhibits cigarette smoke-induced endothelin receptor expression in pulmonary arteries.Eur Respir J2012;39:927-38

[59] Falcetti E,Phillips PG,Morrell NW,Clapp LH.Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension.Am J Respir Crit Care Med2010;182:1161-70 PMCID:PMC3001258

[60] Kuwano K,Asaki T,Yamada T,Kuwabara K.2-[4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetam ide (NS-304), an orally available and long-acting prostacyclin receptor agonist prodrug.J Pharmacol Exp Ther2007;322:1181-8

[61] Schermuly RT,Breitenbach SC,Ghofrani HA,Nilius SM,Kirchrath JM,Rose F.Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs.Respir Res2007;8:4 PMCID:PMC1802745

[62] Gatfield J,Wanner D,Monnier L,Hess P,Clozel M.Selexipag active metabolite ACT-333679 displays strong anticontractile and antiremodeling effects but low beta-arrestin recruitment and desensitization potential.J Pharmacol Exp Ther2017;362:186-99

[63] Chen CH,Hsu YH,Cheng TH,Chen TH.The protective effect of prostacyclin on adriamycin-induced apoptosis in rat renal tubular cells.Eur J Pharmacol2006;529:8-15

[64] Chen HH,Lin H.Prostacyclin-induced peroxisome proliferator-activated receptor-alpha translocation attenuates NF-kappaB and TNF-alpha activation after renal ischemia-reperfusion injury.Am J Physiol Renal Physiol2009;297:F1109-18

[65] Kimura TE,Smith MC,Sala-Newby GB,Bond M.The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.J Mol Cell Cardiol2016;90:1-10 PMCID:PMC4727789

[66] Singh S,Bennett RG.Relaxin activates peroxisome proliferator-activated receptor gamma (PPARgamma) through a pathway involving PPARgamma coactivator 1alpha (PGC1alpha).J Biol Chem2015;290:950-9 PMCID:PMC4294522

[67] Xia J,Dong L,Zhang S,Wumaier G,Wei X,Zhu N.Cefminox, a dual agonist of prostacyclin receptor and peroxisome proliferator-activated receptor-gamma identified by virtual screening, has therapeutic efficacy against hypoxia-induced pulmonary hypertension in rats.Front Pharmacol2018;9:134 PMCID:PMC5829529

[68] Falcetti E,Staels B,Haworth SG.IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues.Biochem Biophys Res Commun2007;360:821-7 PMCID:PMC1997304

[69] Idris-Khodja N,Trindade M,Rehman A,Offermanns S,Neves MF,Schiffrin EL.Vascular smooth muscle cell peroxisome proliferator-activated receptor gamma protects against endothelin-1-induced oxidative stress and inflammation.J Hypertens2017;35:1390-401

[70] Harrington LS,Reed A,Desvergne B,Zhao L.The PPARbeta/delta agonist GW0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension.PLoS One2010;5:e9526 PMCID:PMC2831997

[71] Nemenoff R,Hudish TM,Snee A,Stearman RS,Weiser-Evans M,Keith RL.Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma.Cancer Prev Res (Phila)2008;1:349-56 PMCID:PMC2680197

[72] Lee KS,Park SJ,Min KH,Lee MK,Lee YC.Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of mice.J Allergy Clin Immunol2006;118:120-7

[73] Wang J,Yang K,Chen Y,Duan X,He J,Zhong N,Lu W.Hypoxia inducible factor-1-dependent up-regulation of BMP4 mediates hypoxia-induced increase of TRPC expression in PASMCs.Cardiovasc Res2015;107:108-18 PMCID:PMC4560045

[74] Wang J,Lu W,Semenza GL.Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular Ca2+ in pulmonary arterial smooth muscle cells.Circ Res2006;98:1528-37

[75] Wang Y,Yang K,Zhang J,Yun X,Chen Y,Zhang B,Wang J.Peroxisome proliferator-activated receptor gamma inhibits pulmonary hypertension targeting store-operated calcium entry.J Mol Med (Berl)2015;93:327-42 PMCID:PMC4334731

[76] Chen T,Tang H,Yuan JX,Zhou G.miR-17/20 Controls prolyl hydroxylase 2 (PHD2)/hypoxia-inducible factor 1 (HIF1) to regulate pulmonary artery smooth muscle cell proliferation.J Am Heart Assoc2016;5:

[77] Gusan S.cAMP attenuates the enhanced expression of Gi proteins and hyperproliferation of vascular smooth muscle cells from SHR: role of ROS and ROS-mediated signaling.Am J Physiol Cell Physiol2013;304:C1198-209

[78] Dai Y,Chang J.Rho kinase signaling and cardiac physiology.Curr Opin Physiol2018;1:14-20

[79] Oka M,Taraseviciene-Stewart L,Kraskauskas D,Voelkel NF.Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.Circ Res2007;100:923-9

[80] Zhao L,Ali O,Mamanova L,Wharton J.Simvastatin and sildenafil combine to attenuate pulmonary hypertension.Eur Respir J2009;34:948-57

[81] Yao J,Tang B,Liang M,Wang Z.Simvastatin attenuates pulmonary vascular remodelling by down-regulating matrix metalloproteinase-1 and -9 expression in a carotid artery-jugular vein shunt pulmonary hypertension model in rats.Eur J Cardiothorac Surg2012;42:e121-7

[82] Li X,Tupper JC,Winn RK,Hamilton AD.Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells.J Biol Chem2002;277:15309-16

[83] Kawasaki Y,Sakamoto K,Takaki H,Otashiro T,Yonezawa S,Natori Y.Angiostatin prevents IL-1beta-induced down-regulation of eNOS expression by inhibiting the NF-kappaB cascade.J Pharmacol Sci2015;129:200-4

[84] Niwano K,Koitabashi N,Watanabe A,Tanaka T,Kurabayashi M.Competitive binding of CREB and ATF2 to cAMP/ATF responsive element regulates eNOS gene expression in endothelial cells.Arterioscler Thromb Vasc Biol2006;26:1036-42

[85] Niwano K,Tomaru K,Ohyama Y.Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways.Circ Res2003;93:523-30

[86] Steven S,Dopheide JF,Espinola-Klein C.Peripheral artery disease, redox signaling, oxidative stress - Basic and clinical aspects.Redox Biol2017;12:787-97 PMCID:PMC5403804

[87] Sebkhi A,Phillips SC,Wilkins MR.Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension.Circulation2003;107:3230-5

[88] Paffett ML,Campen MJ.Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.Vascul Pharmacol2012;56:64-73 PMCID:PMC3370653

[89] Maclean MR,McCulloch KM,Houslay MD.Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension.J Pharmacol Exp Ther1997;283:619-24

[90] Amsellem V,Poupel L,Rodero M,Latiri M,Lipskaia L,Adnot S.Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 chemokine systems in hypoxic pulmonary hypertension.Am J Respir Cell Mol Biol2017;56:597-608

[91] Balabanian K,Dorfmuller P,Capel F,Portier A,Krzysiek R,Simonneau G,Humbert M.CX(3)C chemokine fractalkine in pulmonary arterial hypertension.Am J Respir Crit Care Med2002;165:1419-25

[92] Serag AR,Afifi IK,Serag AR.Regulated upon activation, normal T-cell expressed and secreted chemokine and interleukin-6 in rheumatic pulmonary hypertension, targets for therapeutic decisions.Eur J Cardiothorac Surg2010;37:853-8

[93] Launay JM,Callebert J,Collet C,Belmer A,Hatia S,Humbert M.Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension.Blood2012;119:1772-80

[94] Xu J,Oh D,Chen A,Mamane Y,Nawrocki AR,Olefsky JM.GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity.J Immunol2012;189:1992-9 PMCID:PMC3411902

[95] Gerasimovskaya EV,White CW,Carpenter TC.Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth.Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor. J Biol Chem2002;277:44638-50

[96] Woodward HN,Riddle S,Fragoso M,Gerasimovskaya EV.PI3K, Rho, and ROCK play a key role in hypoxia-induced ATP release and ATP-stimulated angiogenic responses in pulmonary artery vasa vasorum endothelial cells.Am J Physiol Lung Cell Mol Physiol2009;297:L954-64 PMCID:PMC2777489

[97] Bodin P.Evidence that release of adenosine triphosphate from endothelial cells during increased shear stress is vesicular.J Cardiovasc Pharmacol2001;38:900-8

[98] Tackett BC,Mei Y,Cheruvu S,Hernandez-Garcia A,Karpen SJ.P2Y2 purinergic receptor activation is essential for efficient hepatocyte proliferation in response to partial hepatectomy.Am J Physiol Gastrointest Liver Physiol2014;307:G1073-87 PMCID:PMC4254960

[99] Burnstock G.The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.Purinergic Signal2018;14:1-18 PMCID:PMC5842154

[100] Idzko M,Eltzschig HK.Nucleotide signalling during inflammation.Nature2014;509:310-7 PMCID:PMC4222675

[101] Stachon P,Michel NA,Marchini T,Dufner B,Ayata CK,Cicko S,Reinohl J,Bode C,Zirlik A.P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.Arterioscler Thromb Vasc Biol2014;34:2237-45

[102] Zhang Z,Ren H,Huang K,Liu M,Qian M.P2Y(6) agonist uridine 5'-diphosphate promotes host defense against bacterial infection via monocyte chemoattractant protein-1-mediated monocytes/macrophages recruitment.J Immunol2011;186:5376-87

[103] Bar I,Metallo J,Wilkin F,Bult H.Knockout mice reveal a role for P2Y6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells.Mol Pharmacol2008;74:777-84

[104] Visovatti SH,Goonewardena SN,Kanthi Y,Wang J,Rattan R,Pinsky DJ.Purinergic dysregulation in pulmonary hypertension.Am J Physiol Heart Circ Physiol2016;311:H286-98 PMCID:PMC4967198

[105] Kylhammar D,Radegran G.P2Y(1) and P2Y(1)(2) receptors in hypoxia- and adenosine diphosphate-induced pulmonary vasoconstriction in vivo in the pig.Eur J Appl Physiol2014;114:1995-2006

[106] Nijmeh H,Burns N,Stenmark KR.High proliferative potential endothelial colony-forming cells contribute to hypoxia-induced pulmonary artery vasa vasorum neovascularization.Am J Physiol Lung Cell Mol Physiol2014;306:L661-71 PMCID:PMC3962625

[107] Karmouty-Quintana H,Acero L,Melicoff E,Hemnes A,Eltzschig HK,Xia Y,Zeng D,Blackburn MR.The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease.FASEB J2012;26:2546-57 PMCID:PMC3650483

[108] Karmouty-Quintana H,Garcia-Morales LJ,Pedroza M,Molina JG,Bruckner BA,Johnston RA,Zeng D,Belardinelli L.Adenosine A2B receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary disease.Am J Respir Cell Mol Biol2013;49:1038-47 PMCID:PMC5459551

[109] Karmouty-Quintana H,Acero LF,Weng T,Luo F,Le NB,Volcik KA,Johnston RA,Eltzschig HK.Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension.FASEB J2015;29:50-60 PMCID:PMC4763976

[110] Xu MH,Su MS,Dai SS,Li N,He JC,Wang XT.Absence of the adenosine A2A receptor confers pulmonary arterial hypertension and increased pulmonary vascular remodeling in mice.J Vasc Res2011;48:171-83 PMCID:PMC2975736

[111] Alencar AK,Montagnoli TL,Kummerle AE,Caruso-Neves C,Tesch R,de Sant'Anna CM,Barreiro EJ,Zapata-Sudo G.Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline-induced pulmonary hypertension in rats.Br J Pharmacol2013;169:953-62 PMCID:PMC3696320

[112] Shang P,Chen JF,Liu BH,Wang XT.Absence of the Adenosine A2A receptor confers pulmonary arterial hypertension through RhoA/ROCK signaling pathway in mice.J Cardiovasc Pharmacol2015;66:569-75

[113] Singh NK,Rao GN.p115 RhoGEF activates the Rac1 GTPase signaling cascade in MCP1 chemokine-induced vascular smooth muscle cell migration and proliferation.J Biol Chem2017;292:14080-91 PMCID:PMC5572933

[114] Norton CE,Jernigan NL,Resta TC.Enhanced depolarization-induced pulmonary vasoconstriction following chronic hypoxia requires EGFR-dependent activation of NAD(P)H oxidase 2.Antioxid Redox Signal2013;18:1777-88 PMCID:PMC3619151

[115] Wang Y,Pan M.ELMO1 directly interacts with gbetagamma subunit to transduce GPCR signaling to Rac1 activation in chemotaxis.J Cancer2016;7:973-83 PMCID:PMC4910590

[116] Nguyen Dinh Cat A,Burger D.Angiotensin II, NADPH oxidase, and redox signaling in the vasculature.Antioxid Redox Signal2013;19:1110-20 PMCID:PMC3771549

[117] Li Y.Microvascular NADPH oxidase in health and disease.Free Radic Biol Med2017;109:33-47 PMCID:PMC5482368

[118] Rastogi R,Li F.NOX activation by subunit interaction and underlying mechanisms in disease.Front Cell Neurosci2016;10:301

[119] Paulsen CE.Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery.Chem Rev2013;113:4633-79 PMCID:PMC4303468

[120] Yu AY,Iyer NV,Sun X,Beaty T,Wiener CM,Semenza GL.Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha.J Clin Invest1999;103:691-6 PMCID:PMC408131

[121] Tan Q,Percy MJ,Chen L,Christofidou-Solomidou M,Lee FS.Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation.J Biol Chem2013;288:17134-44 PMCID:PMC3682519

[122] Zhang L,Li N,He H,Zhang Z.Estrogen stabilizes hypoxia-inducible factor 1alpha through G protein-coupled estrogen receptor 1 in eutopic endometrium of endometriosis.Fertil Steril2017;107:439-47 PMCID:PMC5292292

[123] Li M,Jin F,Li Z,Fang P,Jiang X.Endothelin-1 induces hypoxia inducible factor 1alpha expression in pulmonary artery smooth muscle cells.FEBS Lett2012;586:3888-93

[124] De Francesco EM,Santolla MF,Ricchio E,Maggiolini M.GPER mediates activation of HIF1alpha/VEGF signaling by estrogens.Cancer Res2014;74:4053-64

[125] Ji R,Xu W,Woodward DF.EP1 prostanoid receptor coupling to G i/o up-regulates the expression of hypoxia-inducible factor-1 alpha through activation of a phosphoinositide-3 kinase signaling pathway.Mol Pharmacol2010;77:1025-36 PMCID:PMC2879919

[126] Kasama H,Kasamatsu A,Koyama T,Ogawara K,Shiiba M,Uzawa K.Adenosine A2b receptor promotes progression of human oral cancer.BMC Cancer2015;15:563 PMCID:PMC4520274

[127] Lee SJ,Dang DT,Yang VW,Yun CC.Regulation of hypoxia-inducible factor 1alpha (HIF-1alpha) by lysophosphatidic acid is dependent on interplay between p53 and Kruppel-like factor 5.J Biol Chem2013;288:25244-53 PMCID:PMC3757187

[128] Lee HY,Lee N,Lee C,Moon EY,Park H.Src activates HIF-1alpha not through direct phosphorylation of HIF-1alpha specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway.Carcinogenesis2011;32:703-12

[129] Du J,Hu Z,Zhu Y,Zhou L.PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1alpha expression in MCF-7 breast cancer cells.PLoS One2011;6:e25213 PMCID:PMC3181265

[130] Chang TC,Tam K,Tan KT,Lin TN.Stabilization of hypoxia-inducible factor-1{alpha} by prostacyclin under prolonged hypoxia via reducing reactive oxygen species level in endothelial cells.J Biol Chem2005;280:36567-74

[131] Takabuchi S,Oda S,Oda T,Adachi T.Opioid receptor stimulation does not affect cellular hypoxia-induced gene responses mediated by hypoxia-inducible factor 1 in cultured cell lines.J Anesth2005;19:263-5

[132] Griguer CE,Kelley EE,Lancaster JR., Gillespie GY.Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells. Cancer Res2006;66:2257-63

[133] Xia L,Huang W,Wang Y,Tian D,Chen Z,Chen Z,Fan D,Wu K.The TNF-alpha/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.Carcinogenesis2012;33:2250-9

[134] Lee G,Lee YM,Oh TI,Choi DK,Kim YJ,Puigserver P.Oxidative dimerization of PHD2 is responsible for its inactivation and contributes to metabolic reprogramming via HIF-1alpha activation.Sci Rep2016;6:18928 PMCID:PMC4703963

[135] Fukai K,Hoshino A,Okawa Y,Kaimoto S,Ono K,Ikeda K,Ueyama T.Pyk2 aggravates hypoxia-induced pulmonary hypertension by activating HIF-1alpha.Am J Physiol Heart Circ Physiol2015;308:H951-9

[136] Yang T,Chen G,Ni XH,Ye J,Liu ZH,He JG.Increased levels of plasma CXC-chemokine ligand 10, 12 and 16 are associated with right ventricular function in patients with idiopathic pulmonary arterial hypertension.Heart Lung2014;43:322-7

[137] McCullagh BN,Li L,Codd M,Morton A,Condliffe R,McLoughlin P.Elevated plasma CXCL12alpha is associated with a poorer prognosis in pulmonary arterial hypertension.PLoS One2015;10:e0123709 PMCID:PMC4391833

[138] Kazimierczyk R,Jasiewicz M,Ptaszynska-Kopczynska K,Waszkiewicz E,Musial WJ.Increased platelet content of SDF-1alpha is associated with worse prognosis in patients with pulmonary arterial hypertension.Platelets2018;

[139] Wei L,Cao W,Yu X.Inhibition of CXCL12/CXCR4 suppresses pulmonary arterial smooth muscle cell proliferation and cell cycle progression via PI3K/Akt pathway under hypoxia.J Recept Signal Transduct Res2015;35:329-39

[140] Barst RJ.PDGF signaling in pulmonary arterial hypertension.J Clin Invest2005;115:2691-4 PMCID:PMC1236701

[141] Wang Y,Qin L,Yi T,Zhao L,Tellides G.Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation.Circ Res2007;101:560-9

[142] Little PJ.GPCR responses in vascular smooth muscle can occur predominantly through dual transactivation of kinase receptors and not classical Galphaq protein signalling pathways.Life Sci2013;92:951-6

[143] Dahal BK,Pullamsetti SS,Ghofrani HA,Seeger W,Schermuly RT.Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-beta.Pulm Circ2011;1:259-68 PMCID:PMC3198653

[144] Burch ML,Osman N,Little PJ.Thrombin-mediated proteoglycan synthesis utilizes both protein-tyrosine kinase and serine/threonine kinase receptor transactivation in vascular smooth muscle cells.J Biol Chem2013;288:7410-9 PMCID:PMC3591648

[145] McKean JS,Gibson G,Tucker SJ.The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP.Cardiovasc Res2015;107:546-55 PMCID:PMC4540143

[146] Viedt C,Athanasiou T,Orth SR,Kreuzer J.Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1.Arterioscler Thromb Vasc Biol2002;22:914-20

[147] Ashton AW,Helisch A.Thromboxane A2 receptor agonists antagonize the proangiogenic effects of fibroblast growth factor-2: role of receptor internalization, thrombospondin-1, and alpha(v)beta3.Circ Res2004;94:735-42

[148] Gao Y,Tang S,Ware JA.Reversal of angiogenesis in vitro, induction of apoptosis, and inhibition of AKT phosphorylation in endothelial cells by thromboxane A(2).Circ Res2000;87:739-45

[149] Ashton AW.Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration.Circ Res2004;95:372-9

[150] Strassheim D,Burke DL,Stenmark KR.Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent manner.J Immunol2009;183:6981-8 PMCID:PMC2783325

[151] Ren J,Cai H,Zhao D,Li Z,Wang J,Li Y,Wei H,Liu Y,Ding M.Human GPR4 and the notch signaling pathway in endothelial cell tube formation.Mol Med Rep2016;14:1235-40

[152] Kerr BA,Kim YW,Tischenko M,Phares TW,Bernier-Latmani J,Adams RH,Naga Prasad SV.Stability and function of adult vasculature is sustained by Akt/Jagged1 signalling axis in endothelium.Nat Commun2016;7:10960 PMCID:PMC4793084

[153] Lin CH.Notch signaling governs phenotypic modulation of smooth muscle cells.Vascul Pharmacol2014;63:88-96

[154] Chakravarti B,Ahlers-Dannen KE,Flaherty HA,Anderson ME.Essentiality of regulator of G protein signaling 6 and oxidized Ca(2+)/calmodulin-dependent protein kinase II in Notch signaling and cardiovascular development.J Am Heart Assoc2017;6:

[155] Sangphech N,Palaga T.Notch signaling regulates the phosphorylation of Akt and survival of lipopolysaccharide-activated macrophages via regulator of G protein signaling 19 (RGS19).Immunobiology2014;219:653-60 PMCID:PMC4101182

[156] Ma YX,Feng YJ,Qin XL.G protein coupled receptor 50 promotes self-renewal and neuronal differentiation of embryonic neural progenitor cells through regulation of notch and wnt/beta-catenin signalings.Biochem Biophys Res Commun2015;458:836-42

[157] Feng B,Zhong H,Wang H,Bai M,Wang X.RhoE promotes metastasis in gastric cancer through a mechanism dependent on enhanced expression of CXCR4.PLoS One2013;8:e81709 PMCID:PMC3843694

[158] Collett GP,Linton EA,Sargent IL.RhoE is regulated by cyclic AMP and promotes fusion of human BeWo choriocarcinoma cells.PLoS One2012;7:e30453 PMCID:PMC3260294

[159] Yue X,Yang T,Yi X,Li X,Guo J,Shi J,Youker KA,Yu Y,Chang J.Rnd3/RhoE modulates hypoxia-inducible factor 1alpha/vascular endothelial growth factor signaling by stabilizing hypoxia-inducible factor 1alpha and regulates responsive cardiac angiogenesis.Hypertension2016;67:597-605 PMCID:PMC4752414

[160] Parker AR,Altman MC,Jr.Lipid mediators in aspirin-exacerbated respiratory disease.Immunol Allergy Clin North Am2016;36:749-63

[161] Mitchell JA.Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system.Br J Pharmacol2018;

[162] Fink MP,Menconi MJ,Wang H,Fleisch JH.A novel leukotriene B4-receptor antagonist in endotoxin shock: a prospective, controlled trial in a porcine model.Crit Care Med1993;21:1825-37

[163] Qian J,Jiang X,Sung YK,Tu AB,Jiang S,Fiorentino DF,Peters-Golden M,Chung L,Nicolls MR.Leukotriene B4 activates pulmonary artery adventitial fibroblasts in pulmonary hypertension.Hypertension2015;66:1227-39 PMCID:PMC4646718

[164] Ee MT,Ivanovska J,Jain A.Leukotriene B4 mediates macrophage influx and pulmonary hypertension in bleomycin-induced chronic neonatal lung injury.Am J Physiol Lung Cell Mol Physiol2016;311:L292-302

[165] Tian W,Tamosiuniene R,Qian J,Gera L,Rabinovitch M,Inayathullah M,Rajadas J,Voelkel NF.Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension.Sci Transl Med2013;5:200ra117 PMCID:PMC4016764

[166] Tabata T,Song C,Suzuki S,Fujimura S.Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension.Nihon Kyobu Shikkan Gakkai Zasshi1997;35:160-6

[167] Albertini M.In pigs, inhaled nitric oxide (NO) counterbalances PAF-induced pulmonary hypertension.Prostaglandins Leukot Essent Fatty Acids1994;51:357-62

[168] Ono S.PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension.J Appl Physiol (1985)1991;71:2483-92

[169] Smallbone BW,McDonald JW.Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep.J Pharmacol Exp Ther1987;242:1035-40

[170] Lu A,He Y,Piao L,Xiao B,Tang J,Alberti S,Zuo S,Yan S,Yuan F,Duan S,Lazarus M,Breyer RM,Yu Y.EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-beta1 signaling.J Clin Invest2015;125:1228-42 PMCID:PMC4362262

[171] Toki S,Goleniewska K,Dulek DE,Lawson WE,Jr.Endogenous PGI2 signaling through IP inhibits neutrophilic lung inflammation in LPS-induced acute lung injury mice model.Prostaglandins Other Lipid Mediat2018;136:33-43

[172] Zhou W,Goleniewska K,Ji S,Fitzgerald GA,Geraci MW,Jr.Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells.J Immunol2007;178:702-10

[173] Miyata M,Sekine H,Sakuma F,Nishio S,Kasukawa R.Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension.J Cardiovasc Pharmacol1996;27:20-6

[174] Pickworth J,Iremonger J,Hopkinson K,Gladson S,Morrell NW,West JD.Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling.Pulm Circ2017;7:768-76 PMCID:PMC5703124

[175] Good RB,Trinder SL,Coghlan G,Holmes AM.Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary arterial hypertension.Am J Pathol2015;185:1850-8

[176] Nelin LD,Jin Y,Chen B.The Src family tyrosine kinases src and yes have differential effects on inflammation-induced apoptosis in human pulmonary microvascular endothelial cells.Am J Physiol Lung Cell Mol Physiol2016;310:L880-8 PMCID:PMC5504399

[177] Yu XH,Liu LJ,Tang SL,Tian GP.Apelin and its receptor APJ in cardiovascular diseases.Clin Chim Acta2014;428:1-8

[178] Wu Q,Li J,Wang QL,Fan R,Xu XZ,Yu SQ.Kappa-opioid receptor stimulation improves endothelial function in hypoxic pulmonary hypertension.PLoS One2013;8:e60850 PMCID:PMC3646880

[179] Zhou Y,Wang X,Zhang S,Guo H,Feng N,Gu X,Li J.The protective effects of kappa-opioid receptor stimulation in hypoxic pulmonary hypertension involve inhibition of autophagy through the AMPK-MTOR pathway.Cell Physiol Biochem2017;44:1965-79

[180] Zhang J,Fang Z,Huang F,Zhou S.Hypoxia induces the proliferation of endothelial progenitor cells via upregulation of Apelin/APLNR/MAPK signaling.Mol Med Rep2016;13:1801-6

[181] Zhang H,Wang Z,Chen R,Zhu H,Li X,Kong X.Apelin inhibits the proliferation and migration of rat PASMCs via the activation of PI3K/Akt/mTOR signal and the inhibition of autophagy under hypoxia.J Cell Mol Med2014;18:542-53 PMCID:PMC3955159

[182] Zhang J,Hu X,Huang F,Zhou S.Apelin/APJ signaling promotes hypoxia-induced proliferation of endothelial progenitor cells via phosphoinositide-3 kinase/Akt signaling.Mol Med Rep2015;12:3829-34

[183] Zheng H,Dai T.Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway.J Cardiovasc Pharmacol2007;50:274-80

[184] Foresta C,Di Mambro A,Ferlin A.The PDE5 inhibitor sildenafil increases circulating endothelial progenitor cells and CXCR4 expression.J Sex Med2009;6:369-72

[185] Yaoita N,Fukumoto Y,Miyata S,Nochioka K,Tatebe S,Yamamoto S,Kimura T,Horiuchi H.Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension.Arterioscler Thromb Vasc Biol2014;34:2486-94

[186] Diebold I,Hess J.Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription.Thromb Haemost2008;100:1021-8

[187] Banerjee I,Price RL,Baudino TA.Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse.Am J Physiol Heart Circ Physiol2007;293:H1883-91

[188] Sun F,Zhang Y,Xu M,Huang Y,Zhang Y.Stagedependent changes of beta2adrenergic receptor signaling in right ventricular remodeling in monocrotalineinduced pulmonary arterial hypertension.Int J Mol Med2018;41:2493-504 PMCID:PMC5846663

[189] Wang S,You J,Xue X,Xu L,Yuan L,Luo H,Cui Z.HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.J Mol Cell Cardiol2018;118:193-207

[190] Zhao Y,Chen C,Yin Z,Fan J,Wang DW.MiR-124 aggravates failing hearts by suppressing CD151-facilitated angiogenesis in heart.Oncotarget2018;9:14382-96 PMCID:PMC5865677

[191] Liao X,Zhang R,Vasudevan NT,Sweet DR,Qing Y,Fu C,Hu R,Fujioka H,Cameron MJ,Stamler JS.Distinct roles of resident and nonresident macrophages in nonischemic cardiomyopathy.Proc Natl Acad Sci U S A2018;115:E4661-9

[192] Renaud-Gabardos E,Hantelys F,Calise D,Masri B,Sicard P,Roncalli J,Garmy-Susini B,Prats AC.Therapeutic benefit and gene network regulation by combined gene transfer of apelin, FGF2, and SERCA2a into ischemic heart.Mol Ther2018;26:902-16

[193] Dewachter C,Rondelet B,Schraufnagel DP,Brimioulle S,Naeije R.Myocardial inflammation in experimental acute right ventricular failure: effects of prostacyclin therapy.J Heart Lung Transplant2015;34:1334-45

[194] Wu L,Zhang D,Huang Z,Wang Z,Li P,Liang C.C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway.Free Radic Biol Med2018;121:215-30

[195] Chien PT,Hsiao LD.Induction of HO-1 by carbon monoxide releasing molecule-2 attenuates thrombin-induced COX-2 expression and hypertrophy in primary human cardiomyocytes.Toxicol Appl Pharmacol2015;289:349-59

[196] Ramos-Kuri M,Mehel H,Dhandapany PS,Garcia-Carranca A,Fischmeister R,Lebeche D,Lipskaia L.Dominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophy.Biochim Biophys Acta2015;1853:2870-84 PMCID:PMC4715892

[197] Cortes R,Rosello-Lleti E,Almenar L,Lago F,Portoles M.Differences in MEF2 and NFAT transcriptional pathways according to human heart failure aetiology.PLoS One2012;7:e30915 PMCID:PMC3281902

[198] Aguero J,Hadri L,Fish K,Chaanine A,Naim C,Pereda D,Fuster V,Leopold JA.Characterization of right ventricular remodeling and failure in a chronic pulmonary hypertension model.Am J Physiol Heart Circ Physiol2014;307:H1204-15 PMCID:PMC4200337

[199] Huang J,Yao Y,Ding J,Li H.Pivotal role of regulator of G-protein signaling 12 in pathological cardiac hypertrophy.Hypertension2016;67:1228-36

[200] Ramadas N,Kuppuswamy AA.Early growth response-1 (EGR-1) - a key player in myocardial cell injury.Cardiovasc Hematol Agents Med Chem2014;12:66-71

[201] van der Feen DE,Bartelds B,Sietsma H,Berger RM.Egr-1 identifies neointimal remodeling and relates to progression in human pulmonary arterial hypertension.J Heart Lung Transplant2016;35:481-90

[202] Dickinson MG,Bartelds B,van der Feen D,Molema G,Berger RM.A critical role for Egr-1 during vascular remodelling in pulmonary arterial hypertension.Cardiovasc Res2014;103:573-84

[203] Lemon DD,Horn TR,Ferguson BS,McKinsey TA.Promiscuous actions of small molecule inhibitors of the protein kinase D-class IIa HDAC axis in striated muscle.FEBS Lett2015;589:1080-8 PMCID:PMC4410688

[204] Vega RB,Meadows E,Papst PJ,McKinsey TA.Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5.Mol Cell Biol2004;24:8374-85 PMCID:PMC516754

[205] Yang L,Mo R,Hua H,Feng Y,Zhang WY,Mo XM.The succinate receptor GPR91 is involved in pressure overload-induced ventricular hypertrophy.PLoS One2016;11:e0147597 PMCID:PMC4732750

[206] Yang L,Fan HH,Hu L,Zhou K.Triggering the succinate receptor GPR91 enhances pressure overload-induced right ventricular hypertrophy.Int J Clin Exp Pathol2014;7:5415-28 PMCID:PMC4203155

[207] Deschamps AM.Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats.Am J Physiol Heart Circ Physiol2009;297:H1806-13 PMCID:PMC2781389

[208] Bopassa JC,Toro L.A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury.Am J Physiol Heart Circ Physiol2010;298:H16-23 PMCID:PMC2806134

[209] Nunn C,Sobiesiak AJ,Kirshenbaum LA.RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy.Cell Signal2010;22:1231-9

[210] Lee KN,Nguyen C,Chidiac P.Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice.J Mol Cell Cardiol2017;108:194-202

[211] Sjogren B,Atkins KB,Neubig RR.Digoxin-mediated upregulation of RGS2 protein protects against cardiac injury.J Pharmacol Exp Ther2016;357:311-9 PMCID:PMC4851323

[212] Takimoto E,Hsu S,Zhang M,Bedja D,Blanton R,Mendelsohn ME.Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice.J Clin Invest2009;119:408-20

[213] Tokudome T,Horio T,Schwenke DO,Okano I,Kohno M,Nakao K.Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.Circulation2008;117:2329-39

[214] Yang J,Huang J,Stewart A,Anderson ME.G-protein inactivator RGS6 mediates myocardial cell apoptosis and cardiomyopathy caused by doxorubicin.Cancer Res2013;73:1662-7 PMCID:PMC3602152

[215] Miao R,Xing X,Huang Z,Huang Y,Tang X,Cai J.Regulator of G-protein signaling 10 negatively regulates cardiac remodeling by blocking mitogen-activated protein kinase-extracellular signal-regulated protein kinase 1/2 signaling.Hypertension2016;67:86-98

[216] Li Y,Li XH,Miao RJ,Huang ZJ,Xing XW,Yuan H.Regulator of G protein signalling 14 attenuates cardiac remodelling through the MEK-ERK1/2 signalling pathway.Basic Res Cardiol2016;111:47 PMCID:PMC4906057

[217] Xiao Y,Liu J.The association between myocardial fibrosis and depressed capillary density in rat model of left ventricular hypertrophy.Cardiovasc Toxicol2018;18:304-1

[218] Jabs M,Lehmann LH,Moll I,Herberich SE,Poschet G,Mogler C,Augustin HG,Gretz N,Adams RH,Hell R,Backs J,Herzig S.Inhibition of endothelial notch signaling impairs fatty acid transport and leads to metabolic and vascular remodeling of the adult heart.Circulation2018;137:2592-608

[219] Kumar R,Kassa B,Robinson JC,Sanders L,Meadows C,Irwin D,McKeon BA,Dale Brown R,Evans CM,Bandeira A,Bull TM,Stenmark KR,Graham BB.TGF-beta activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension.Nat Commun2017;8:15494 PMCID:PMC5459967

[220] Gong H,Sassmann A,Mastej V,Zhang W,Offermanns S,Malik AB.PAR1 scaffolds TGFbetaRII to downregulate TGF-beta signaling and activate ESC differentiation to endothelial cells.Stem Cell Reports2016;7:1050-8 PMCID:PMC5161529

[221] Zhou L,Mao X,Baker PN.G-protein-coupled receptor 30 mediates the effects of estrogen on endothelial cell tube formation in vitro.Int J Mol Med2017;39:1461-7 PMCID:PMC5428938

[222] Li Z,Liang H,Hu J,Yang J,Zhao M.GPER inhibits diabetes-mediated RhoA activation to prevent vascular endothelial dysfunction.Eur J Cell Biol2016;95:100-13

[223] Glembotski CC,Krown KA,Sprenkle AB.Myocardial alpha-thrombin receptor activation induces hypertrophy and increases atrial natriuretic factor gene expression.J Biol Chem1993;268:20646-52

[224] Ide J,Ishivata S,Strukova SM.Proteinase-activated receptor agonists stimulate the increase in intracellular Ca2+ in cardiomyocytes and proliferation of cardiac fibroblasts from chick embryos.Bull Exp Biol Med2007;144:760-3

[225] Snead AN.Defining the cellular repertoire of GPCRs identifies a profibrotic role for the most highly expressed receptor, protease-activated receptor 1, in cardiac fibroblasts.FASEB J2012;26:4540-7 PMCID:PMC3475245

[226] Nishida M,Uemura A,Tozaki-Saitoh H,Ide T,Inoue K,Kurose H.P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis.EMBO J2008;27:3104-15 PMCID:PMC2599880

[227] Samuel CS,Bathgate RA.'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease.Pharmacol Ther2006;112:529-52

[228] Chen Y,Yao W,Xu X,Zhang W.Prostacyclin analogue beraprost inhibits cardiac fibroblast proliferation depending on prostacyclin receptor activation through a TGF beta-Smad signal pathway.PLoS One2014;9:e98483 PMCID:PMC4031177

[229] Salvi V,Sozzani S.Role of atypical chemokine receptors in microglial activation and polarization.Front Aging Neurosci2017;9:148 PMCID:PMC5445112

[230] Pullamsetti SS.Macrophage regulation during vascular remodeling: implications for pulmonary hypertension therapy.Am J Respir Cell Mol Biol2017;56:556-8

[231] Li Y,Wang H,Gu W,Hao H,Yi P,Miao S.Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2.Oncogene2011;30:3887-99

[232] Csoka B,Koscso B,Pacher P,Kepka-Lenhart D,Jr., Gause WC, Leibovich SJ, Hasko G.Adenosine promotes alternative macrophage activation via A2A and A2B receptors. FASEB J2012;26:376-86 PMCID:PMC3250237

[233] Lin HH.G Protein-coupled receptors in macrophages.Microbiol Spectr2016;4:

[234] Eruslanov E,Ortiz J,Kusmartsev S.Pivotal advance: tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE(2) catabolism in myeloid cells.J Leukoc Biol2010;88:839-48

[235] Kruger A,Roch T,Lendlein A.Angiogenically stimulated alternative monocytes maintain their pro-angiogenic and non-inflammatory phenotype in long-term co-cultures with HUVEC.Clin Hemorheol Microcirc2014;58:229-40

[236] Presta M,Leali D,Ronca R.Inflammatory cells and chemokines sustain FGF2-induced angiogenesis.Eur Cytokine Netw2009;20:39-50

[237] Sidibe A,Jemelin S,Poittevin M,Bradfield PF.Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours.Nat Commun2018;9:355 PMCID:PMC5783934

[238] Dopheide JF,Rubrech J,Zeller GC,Dorweiler B,Munzel T,Espinola-Klein C.Inflammation is associated with a reduced number of pro-angiogenic Tie-2 monocytes and endothelial progenitor cells in patients with critical limb ischemia.Angiogenesis2016;19:67-78

[239] Welihinda AA.Positive allosteric modulation of the adenosine A2a receptor attenuates inflammation.J Inflamm (Lond)2014;11:37 PMCID:PMC4253011

[240] Dufton N,Brancaleone V,Patel HB,D'Acquisto F,Perretti M.Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.J Immunol2010;184:2611-9 PMCID:PMC4256430

[241] Ivy DD,Colvin K,Oka M,Gebb S.Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.Circulation2005;111:2988-96 PMCID:PMC1934986

[242] Cha SA,Kim SH.Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor.Korean J Physiol Pharmacol2018;22:447-56 PMCID:PMC6019878

[243] Weng M,Leyton P,Scherer PE,Medoff BD.Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.Am J Respir Cell Mol Biol2011;45:340-7 PMCID:PMC3175561

[244] Hemnes AR,Austin EA,Carrier EJ,Fessel JP,Fong P,Gerszten RE,Kaplowitz M,Piana R,Rice TW,Wheeler L,Loyd JE.A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension.Eur Respir J2018;

[245] Tozzi CA,McHugh NA,Grove BH,Unemori EN.Recombinant human relaxin reduces hypoxic pulmonary hypertension in the rat.Pulm Pharmacol Ther2005;18:346-53

[246] Pintalhao M,Vasques-Novoa F,Mendonca L,Lourenco P,Leite-Moreira A.Relaxin serum levels in acute heart failure are associated with pulmonary hypertension and right heart overload.Eur J Heart Fail2017;19:218-25

[247] Imamura M,Limbird JN,Fallon MB.Endothelin-B receptor overexpression prevents hypoxic pulmonary hypertension in cirrhotic rats.Chest2005;128:580S-1S

[248] Reichenberger F,Steveling E,Kreckel A,Grimminger F,Ghofrani HA.Sildenafil treatment for portopulmonary hypertension.Eur Respir J2006;28:563-7

[249] Xiao R,Feng T,Liu B,Lu Y,Wang T,Hu Q.Monocrotaline induces endothelial injury and pulmonary hypertension by targeting the extracellular calcium-sensing receptor.J Am Heart Assoc2017;6:pii: e004865

[250] West JD,Pavliv L,Hemnes AR.Antagonism of the thromboxane-prostanoid receptor is cardioprotective against right ventricular pressure overload.Pulm Circ2016;6:211-23 PMCID:PMC4869926

[251] West JD,Bloodworth NC,Chen P,Gladson S,Hutcheson JD.Serotonin 2B receptor antagonism prevents heritable pulmonary arterial hypertension.PLoS One2016;11:e0148657 PMCID:PMC4749293

[252] Tian W,Sung YK,Yuan K.Leukotrienes in pulmonary arterial hypertension.Immunol Res2014;58:387-93 PMCID:PMC4031261

[253] Pyne NJ.Sphingosine kinase 1: a potential therapeutic target in pulmonary arterial hypertension?.Trends Mol Med2017;23:786-98

[254] Sysol JR,Machado RF.PDGF induces SphK1 expression via Egr-1 to promote pulmonary artery smooth muscle cell proliferation.Am J Physiol Cell Physiol2016;310:C983-92 PMCID:PMC4935200

[255] Bhavanam NP,Cho Y,Kolliputi N.Commentary: the sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension.Front Pharmacol2015;6:229 PMCID:PMC4610201